Provided by Tiger Trade Technology Pte. Ltd.

RACE ONCOLOGY LTD

2.150
-0.100-4.44%
Volume:38.50K
Turnover:85.03K
Market Cap:421.55M
PE:-34.73
High:2.250
Open:2.250
Low:2.150
Close:2.250
52wk High:4.900
52wk Low:1.200
Shares:196.07M
Float Shares:121.21M
Volume Ratio:0.57
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.062
EPS(LYR):-0.062
ROE:-42.28%
ROA:-23.40%
PB:11.57
PE(LYR):-34.73

Loading ...

Company Profile

Company Name:
RACE ONCOLOGY LTD
Exchange:
ASX
Establishment Date:
2011
Employees:
- -
Office Location:
Gateway, 1 Macquarie Place,Level 36,Sydney,New South Wales,Australia
Zip Code:
2000
Fax:
61 2 8051 3043
Introduction:
Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It is developing Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Melbourne, Australia.